Ceprotin Kit
Product Images NDC 0944-4177

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Ceprotin (NDC 0944-4177). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image (Ceprotin 01)

CEPROTIN Protein C Concentrate Human plasma derivative kit packaging label from Takeda Pharmaceuticals America, Inc. The label features a blue bar design with white text on a dark background.*

FDA Label Image

Image (Ceprotin 02)

FDA Label Image

Logo 1 (Ceprotin 11)

FDA Label Image

Image (Ceprotin 03)

The image shows a product label for CEPROTIN Protein C Concentrate Human, a plasma derivative in kit form. The label includes the proprietary product name prominently on a blue bar, indicating Takeda Pharmaceuticals America, Inc. as the labeler. The label is simple with a strong blue background for the product name.*

FDA Label Image

Image (Ceprotin 04)

FDA Label Image

Principal Display Panel (Kit Carton)

CEPROTIN Protein C Concentrate (Human) single-dose vial kit packaging label. The product is a lyophilized powder for solution for injection. The label displays instructions for intravenous administration only and storage details, including refrigeration temperature. Contains sterile water for injection, transfer needle, and filter needle. Labeler is Takeda Pharmaceuticals America, Inc. with branding from Shire and Baxalta US Inc.*

FDA Label Image

Principal Display Panel (Vial Label)

Label for CEPROTIN Protein C Concentrate (Human) single-dose vial. It is a lyophilized powder for solution for injection, intended for intravenous administration only. The label includes the NDC 0944-4176-01, manufacturer information (Baxalta US Inc., Lexington, MA), and placeholders for dose (IU/vial), lot, and expiration date.*

FDA Label Image

Principal Display Panel (Kit Carton)

CEPROTIN Protein C Concentrate (Human) single-dose vial kit packaging label. The label shows the product as lyophilized powder for solution for injection, labeled by Shire and marketed by Takeda Pharmaceuticals America, Inc. It specifies the product is for intravenous administration only, sterile with no preservatives, and provides storage and reconstitution instructions along with manufacturing and trademark details. The label includes barcodes and lot number placeholders.*

FDA Label Image

Principal Display Panel (Vial Label)

Label for CEPROTIN Protein C Concentrate (Human) single-dose vial, lyophilized powder for solution for injection. For intravenous administration only. The label shows the Shire and Baxalta US Inc. names, NDC 0944-4178-02, and spaces for IU/vial, lot number, and expiration date. Manufactured by Takeda Pharmaceuticals America, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.